ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 45 filers reported holding ATYR PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,144,855 | -27.5% | 1,357,503 | -0.9% | 0.00% | – |
| Q2 2023 | $2,959,543 | +328.1% | 1,370,159 | +316.2% | 0.00% | – |
| Q1 2023 | $691,272 | +17.4% | 329,177 | +22.4% | 0.00% | – |
| Q4 2022 | $588,992 | -26.5% | 268,946 | +0.7% | 0.00% | – |
| Q3 2022 | $801,000 | +4.7% | 267,098 | -1.1% | 0.00% | – |
| Q2 2022 | $765,000 | -48.2% | 270,157 | -2.2% | 0.00% | – |
| Q1 2022 | $1,478,000 | -28.1% | 276,159 | +0.3% | 0.00% | – |
| Q4 2021 | $2,057,000 | +4.4% | 275,379 | +26.9% | 0.00% | – |
| Q3 2021 | $1,970,000 | +79.6% | 217,012 | -3.5% | 0.00% | – |
| Q2 2021 | $1,097,000 | -2.7% | 224,877 | -11.3% | 0.00% | – |
| Q1 2021 | $1,127,000 | +622.4% | 253,389 | +528.3% | 0.00% | – |
| Q4 2020 | $156,000 | +16.4% | 40,331 | -2.6% | 0.00% | – |
| Q3 2020 | $134,000 | -9.5% | 41,411 | +23.8% | 0.00% | – |
| Q2 2020 | $148,000 | +516.7% | 33,463 | +291.4% | 0.00% | – |
| Q1 2020 | $24,000 | -33.3% | 8,549 | 0.0% | 0.00% | – |
| Q4 2019 | $36,000 | +20.0% | 8,549 | -0.0% | 0.00% | – |
| Q3 2019 | $30,000 | – | 8,552 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 624,000 | $1,367 | 2.16% |
| Tikvah Management LLC | 1,350,833 | $2,958,324 | 1.41% |
| VR Adviser, LLC | 1,171,436 | $2,565,445 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 123,430 | $270,312 | 0.04% |
| FEDERATED HERMES, INC. | 5,231,600 | $11,457,204 | 0.03% |
| Alyeska Investment Group, L.P. | 1,378,747 | $3,019,456 | 0.03% |
| Walleye Capital LLC | 750,000 | $1,642,500 | 0.03% |
| Tower Research Capital LLC (TRC) | 17,443 | $38 | 0.00% |
| CITIGROUP INC | 428,460 | $938,327 | 0.00% |
| PFS Partners, LLC | 406 | $890 | 0.00% |